Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Amoxicillin Clavulanate Potassium Powder for Suspension has been deemed to have passed the generic drug quality and efficacy consistency evaluation.
Baiyunshan (00874) issued a announcement that in recent days, the company's subsidiary Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyun...
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Medicine Group Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory ("Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory"), has received a "Notice of Supplementary Application Approval" issued by the National Medical Products Administration. Amoxicillin clavulanate potassium dry powder for suspension has been deemed to pass the generic drug quality and efficacy consistency evaluation.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
